Explore more publications!

The Paraguay Times Press Releases

Labels On
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
Info
Nanotechnology in Cancer Treatment Market Positioned for Transformational Growth by 2029
Bitfarms Reports First Quarter 2025 Results
Pomerantz Law Firm Announces the Filing of a Class Action Against Bitfarms Ltd. and Certain Officers – BITF
BITF Lead Plaintiff Deadline Approaching – BITF Stockholders Should Contact Robbins LLP for Information About Leading the Bitfarms, Ltd. Class Action Lawsuit
Trabajo24.ai Launches its Reward and Payment Token $T24
Bitfarms Announces Partnership with T5 Data Centers to Advance HPC/AI Development at Panther Creek Campus
Pomerantz Law Firm Announces the Filing of a Class Action Against Bitfarms Ltd. and Certain Officers – BITF
Pomerantz Law Firm Announces the Filing of a Class Action Against Bitfarms Ltd. and Certain Officers – BITF
Pomerantz Law Firm Announces the Filing of a Class Action Against Bitfarms Ltd. and Certain Officers – BITF
Robbins LLP Reminds Bitfarms, Ltd. Stockholders of the Class Action Against BITF – Contact Us for Information
HydroGraph CEO to Speak at Prestigious Hemispheric Security Conference and Lead May Investor Roundtable
Prime Minister Carney meets with leaders on the margins of the inaugural Mass of His Holiness Pope Leo XIV

Prime Minister Carney meets with leaders on the margins of the inaugural Mass of His Holiness Pope Leo XIV

WebAccountPlus and OpenKM Announce Strategic Global Partnership for SME Digitalization
BITF Investor Notice: Robbins LLP Reminds Stockholders of the Securities Class Action Against Bitfarms Ltd.
Pomerantz Law Firm Announces the Filing of a Class Action Against Bitfarms Ltd. and Certain Officers – BITF
BITF Class Action Alert: Robbins LLP Reminds Bitfarms, Ltd. Stockholders of the Pending Lead Plaintiff Deadline of July 8, 2025
Bitfarms Provides April 2025 Production and Operations Update
The European Magazine Announces Award Winners 2025
FDA Approves Expanded Indication for AJOVY® (fremanezumab-vfrm), The First Anti-CGRP Preventive Treatment for Pediatric Episodic Migraine
Pomerantz Law Firm Announces the Filing of a Class Action Against Bitfarms Ltd. and Certain Officers – BITF

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions